T. Morita et al., STUDIES OF THYROID XENOGRAFTS FROM GRAVES-DISEASE IN SEVERE COMBINED IMMUNODEFICIENT MICE, The Journal of clinical endocrinology and metabolism, 77(1), 1993, pp. 255-261
Thyroid tissues from normal (paranodular) subjects and patients with G
raves' disease (GD) and Hashimoto's thyroiditis (HT) were xenografted
to severe combined immunodeficiency (SCID) mice, and the same tissues
were engrafted into nude mice; in addition, peripheral blood mononucle
ar cells were engrafted to separate SCID mice (SCID-PB). Thyroglobulin
(TG) and microsomal antibodies (Abs) became detectable with high tite
rs by hemagglutination assays in SCID mice xenografted with thyroid ti
ssues (SCID-TH) from GD and HT patients; moreover, TG Ab was detectabl
e even in SCID-TH from TG Ab-negative GD and HT donors. On the other h
and, only 2 of 10 SCID-PB had detectable Abs with low titers. TSH rece
ptor (TSH-R) Ab was detectable in all sets of SCID-TH from GD. After p
eaking (3-7 weeks), their levels decreased despite the fact that immun
oglobulin G levels increased. In addition, in 3 of 4 sets of SCID-PB f
rom GD patients, TSH-R Ab was also detectable. SCID-TH from GD and HT
patients showed transient hyperthyroxinemia, peaking at 2 weeks; these
values were significantly higher [free T4, 6.48 +/- 0.90 and 5.50 +/-
0.77 pmol/L (mean +/- SE), respectively; P < 0.05] than SCID-TH from
normal controls (2.5 +/- 0.24). Histologically, intrathyroidal infiltr
ating lymphocytes (ITL) survived in SCID mice, but not in nude mice af
ter 8 weeks. The follicles of GD tissue in SCID mice were virtually de
stroyed with ITL, and their appearance was similar to that in HT. In c
onclusion, TSH-R Ab was clearly produced from ITL, and some peripheral
blood mononuclear cells grafts could also produce TSH-R Ab. In spite
of the presence of TSH-R Ab, SCID-TH from GD patients did not show per
sistent hyperthyroxinemia, presumably because destructive thyroiditis
may be occurring in the grafted tissue, with decreasing levels of TSH-
R Ab.